Cargando...

Autotaxin in Pathophysiology and Pulmonary Fibrosis

Lysophospholipid signaling is emerging as a druggable regulator of pathophysiological responses, and especially fibrosis, exemplified by the relative ongoing clinical trials in idiopathic pulmonary fibrosis (IPF) patients. In this review, we focus on ectonucleotide pyrophosphatase-phosphodiesterase...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Front Med (Lausanne)
Main Authors: Ninou, Ioanna, Magkrioti, Christiana, Aidinis, Vassilis
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Media S.A. 2018
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6008954/
https://ncbi.nlm.nih.gov/pubmed/29951481
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2018.00180
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!